Top Eminent Healthcare swings to HK$1.4 million profit in 1H FY26; revenue rises 70.5% to HK$70.9 million

• Top Eminent Healthcare posted a profit attributable to shareholders of HK$1.37 million for the six months ended June 30, returning to profit.
• Total income climbed 64.9% to HK$74.51 million, driven by healthcare products revenue rising 70.5% to HK$70.87 million.
• Profit before tax swung to HK$2.09 million as other operating expenses rose to HK$29.41 million, including HK$4.11 million of litigation-related costs.
• Cash and bank balances totaled HK$212.84 million at June 30, up from end-2025, while net assets attributable to shareholders reached HK$242.8 million.
• Management said it remains cautiously optimistic for 2H 2026, targeting expansion across B2B distribution and B2C e-commerce, with no interim dividend declared.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Top Eminent Healthcare Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260817-12286328), on August 17, 2026, and is solely responsible for the information contained therein.